FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1506818571> ?p ?o ?g. }

• W1506818571 endingPage "21635" @default.
• W1506818571 startingPage "21628" @default.
• W1506818571 abstract "We previously reported that the level of microRNA (miR)-145 is attenuated in human bladder cancer cells. In this current study, we investigated whether intravesical administration of miR-145 could be a potential therapeutic strategy for controlling bladder cancer by using an orthotopic human bladder cancer xenograft model. Following transfection of 253J B-V cells with miR-145, the effects of the ectopic expression of miR-145 were examined by performing MTT, Western blotting analysis, Hoechst33342 staining, and wound healing assay in vitro. Also, a mouse orthotopic human bladder cancer model was established by inoculating 253J B-V cells into the bladder wall of mice. The anti-cancer effects of intravesical injections of miR-145 into these mice were then assessed. Transfection of 253J B-V cells with miR-145 induced apoptosis and suppression of cell migration in vitro. Western blotting showed that the levels of c-Myc, socs7, FSCN1, E-cadherin, β-catenin, and catenin δ-1 were decreased and that the PI3K/Akt and Erk1/2 signaling pathways were increased in compensatory fashion. In vivo, mice treated with miR-145 showed 76% inhibition of tumor growth, with a significant prolongation of animal survival (p = 0.0183 vs. control). Western blotting showed that both apoptosis and cell motility-related genes were significantly decreased as seen in vitro. Furthermore, PI3k/Akt and Erk1/2 signaling pathways, which were activated in a compensatory manner in vitro, were decreased in vivo. Intravesical administration of exogenous miR-145 was thus concluded to be a valid therapy for bladder cancer in this human bladder cancer xenograft model." @default.
• W1506818571 created "2016-06-24" @default.
• W1506818571 creator A5003587912 @default.
• W1506818571 creator A5010445228 @default.
• W1506818571 creator A5011844493 @default.
• W1506818571 creator A5017198710 @default.
• W1506818571 creator A5023997019 @default.
• W1506818571 creator A5029100598 @default.
• W1506818571 creator A5030580122 @default.
• W1506818571 creator A5031903186 @default.
• W1506818571 creator A5036689077 @default.
• W1506818571 creator A5040122887 @default.
• W1506818571 creator A5041446188 @default.
• W1506818571 creator A5043483286 @default.
• W1506818571 creator A5046810835 @default.
• W1506818571 creator A5049167958 @default.
• W1506818571 creator A5065751906 @default.
• W1506818571 creator A5071593174 @default.
• W1506818571 creator A5074215251 @default.
• W1506818571 creator A5082726168 @default.
• W1506818571 date "2015-05-12" @default.
• W1506818571 modified "2023-10-02" @default.
• W1506818571 title "Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft" @default.
• W1506818571 cites W1711618159 @default.
• W1506818571 cites W1850481091 @default.
• W1506818571 cites W1966197897 @default.
• W1506818571 cites W1977218806 @default.
• W1506818571 cites W1997813643 @default.
• W1506818571 cites W2003826003 @default.
• W1506818571 cites W2009452083 @default.
• W1506818571 cites W2011826559 @default.
• W1506818571 cites W2030900217 @default.
• W1506818571 cites W2037090973 @default.
• W1506818571 cites W2045692024 @default.
• W1506818571 cites W2073118251 @default.
• W1506818571 cites W2074267511 @default.
• W1506818571 cites W2090551514 @default.
• W1506818571 cites W2094690684 @default.
• W1506818571 cites W2115135540 @default.
• W1506818571 cites W2140074947 @default.
• W1506818571 cites W2145571102 @default.
• W1506818571 cites W2145704390 @default.
• W1506818571 cites W2155445572 @default.
• W1506818571 cites W2158448236 @default.
• W1506818571 cites W2170274551 @default.
• W1506818571 doi "https://doi.org/10.18632/oncotarget.4129" @default.
• W1506818571 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4673291" @default.
• W1506818571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26036261" @default.
• W1506818571 hasPublicationYear "2015" @default.
• W1506818571 type Work @default.
• W1506818571 sameAs 1506818571 @default.
• W1506818571 citedByCount "28" @default.
• W1506818571 countsByYear W15068185712015 @default.
• W1506818571 countsByYear W15068185712016 @default.
• W1506818571 countsByYear W15068185712017 @default.
• W1506818571 countsByYear W15068185712018 @default.
• W1506818571 countsByYear W15068185712019 @default.
• W1506818571 countsByYear W15068185712021 @default.
• W1506818571 countsByYear W15068185712022 @default.
• W1506818571 countsByYear W15068185712023 @default.
• W1506818571 crossrefType "journal-article" @default.
• W1506818571 hasAuthorship W1506818571A5003587912 @default.
• W1506818571 hasAuthorship W1506818571A5010445228 @default.
• W1506818571 hasAuthorship W1506818571A5011844493 @default.
• W1506818571 hasAuthorship W1506818571A5017198710 @default.
• W1506818571 hasAuthorship W1506818571A5023997019 @default.
• W1506818571 hasAuthorship W1506818571A5029100598 @default.
• W1506818571 hasAuthorship W1506818571A5030580122 @default.
• W1506818571 hasAuthorship W1506818571A5031903186 @default.
• W1506818571 hasAuthorship W1506818571A5036689077 @default.
• W1506818571 hasAuthorship W1506818571A5040122887 @default.
• W1506818571 hasAuthorship W1506818571A5041446188 @default.
• W1506818571 hasAuthorship W1506818571A5043483286 @default.
• W1506818571 hasAuthorship W1506818571A5046810835 @default.
• W1506818571 hasAuthorship W1506818571A5049167958 @default.
• W1506818571 hasAuthorship W1506818571A5065751906 @default.
• W1506818571 hasAuthorship W1506818571A5071593174 @default.
• W1506818571 hasAuthorship W1506818571A5074215251 @default.
• W1506818571 hasAuthorship W1506818571A5082726168 @default.
• W1506818571 hasBestOaLocation W15068185711 @default.
• W1506818571 hasConcept C104317684 @default.
• W1506818571 hasConcept C121608353 @default.
• W1506818571 hasConcept C126322002 @default.
• W1506818571 hasConcept C145059251 @default.
• W1506818571 hasConcept C150903083 @default.
• W1506818571 hasConcept C190283241 @default.
• W1506818571 hasConcept C202751555 @default.
• W1506818571 hasConcept C207001950 @default.
• W1506818571 hasConcept C2780352672 @default.
• W1506818571 hasConcept C502942594 @default.
• W1506818571 hasConcept C54009773 @default.
• W1506818571 hasConcept C54355233 @default.
• W1506818571 hasConcept C55493867 @default.
• W1506818571 hasConcept C71924100 @default.
• W1506818571 hasConcept C75217442 @default.
• W1506818571 hasConcept C81885089 @default.
• W1506818571 hasConcept C85265743 @default.
• W1506818571 hasConcept C86554907 @default.

• next